{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T08:50:30Z","timestamp":1782377430711,"version":"3.54.5"},"reference-count":5,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.clinthera.2026.03.021","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T03:53:42Z","timestamp":1776311622000},"page":"480-482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["YUVIWEL\u24c7 (navepegritide)"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8044-4802","authenticated-orcid":false,"given":"Paul","family":"Beninger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2026.03.021_sbref0001","series-title":"FDA approves drug for pediatric patients with most common form of dwarfism","author":"US Food and Drug Administration. News & Events for Human Drugs","year":"2026"},{"key":"10.1016\/j.clinthera.2026.03.021_bib0002","unstructured":"Yuviwel. Prescribing Information. https:\/\/share.google\/58xU5tv8wjRNvNoAH. Accessed March 6, 2026."},{"key":"10.1016\/j.clinthera.2026.03.021_bib0003","unstructured":"Investing.com. BofA raises Ascendis Pharma stock price target on Yuviwel pricing. https:\/\/www.investing.com\/news\/analyst-ratings\/bofa-raises-ascendis-pharma-stock-price-target-on-yuviwel-pricing-93CH-4545567. Accessed March 6, 2026."},{"key":"10.1016\/j.clinthera.2026.03.021_bib0004","unstructured":"Chamarthi VS, Chamarthi S, Karsonovich T. Achondroplasia. StatPearls. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK559263\/. Last updated December 13, 2025. Accessed March 6, 2026."},{"key":"10.1016\/j.clinthera.2026.03.021_sbref0005","series-title":"Expedited programs for serious conditions | Drugs and Biologics","author":"US Food and Drug Administration","year":"2014"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291826000974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291826000974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T08:33:44Z","timestamp":1782376424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291826000974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":5,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0149291826000974"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2026.03.021","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"YUVIWEL\u24c7 (navepegritide)","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2026.03.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}